Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Citron

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Antimicrobial Agents and Chemotherapy|September 3, 1999
In vitro activity of gemifloxacin (SB 265805) against anaerobesE J Goldstein, D M Citron, Y Warren, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobesE J Goldstein, D M Citron, C V Merriam, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2010
In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteriaD M Citron, K L Tyrrell, C V Merriam, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolatesE J Goldstein, D M Citron, S Hunt Gerardo, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humansE J Goldstein, D M Citron, M Hudspeth, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humansE J Goldstein, D M Citron, S Hunt Gerardo, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 1998
Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogensE J Goldstein, D M Citron, M Hudspeth, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infectionsE J Goldstein, D M Citron, C Vreni Merriam, et al.
The Journal of Infectious Diseases|November 1, 1979
Bacteriology of rattlesnake venom and implications for therapyE J Goldstein, D M Citron, H Gonzalez, et al.
Journal of Clinical Microbiology|May 15, 1999
Characterization of Bacteroides forsythus strains from cat and dog bite wounds in humans and comparison with monkey and human oral strainsM K Hudspeth, S Hunt Gerardo, M F Maiden, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|September 3, 1999
In vitro activity of gemifloxacin (SB 265805) against anaerobesE J Goldstein, D M Citron, Y Warren, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobesE J Goldstein, D M Citron, C V Merriam, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2010
In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteriaD M Citron, K L Tyrrell, C V Merriam, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolatesE J Goldstein, D M Citron, S Hunt Gerardo, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humansE J Goldstein, D M Citron, M Hudspeth, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humansE J Goldstein, D M Citron, S Hunt Gerardo, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 1998
Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogensE J Goldstein, D M Citron, M Hudspeth, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infectionsE J Goldstein, D M Citron, C Vreni Merriam, et al.
The Journal of Infectious Diseases|November 1, 1979
Bacteriology of rattlesnake venom and implications for therapyE J Goldstein, D M Citron, H Gonzalez, et al.
Journal of Clinical Microbiology|May 15, 1999
Characterization of Bacteroides forsythus strains from cat and dog bite wounds in humans and comparison with monkey and human oral strainsM K Hudspeth, S Hunt Gerardo, M F Maiden, et al.
Pageof 12